VERMALAB

 

CARDIOMETABOLIC RESEARCH

Dr. Subodh Verma

Example frontpage image

 

 

 

 

In just over a decade and a half, Dr Subodh Verma has staunchly established himself as an expert Canadian clinician-scientist in vascular biology, endothelial dysfunction and atherosclerosis. With a Bachelor’s degree in pharmacy and a PhD in cardiovascular pharmacology, both from the University of British Columbia, Dr Verma went on to pursue an MD degree and research fellowship in Cardiology at the University of Calgary. This was followed by FRCSC training at the University of Toronto which has culminated in his present appointment as Staff Cardiac Surgeon and Associate Professor at St Michael’s Hospital, University of Toronto

Dr Verma is the recipient of numerous accolades. On the national level, his awards include an Medical Research Council fellowship (ranked 1st of 412), a Heart and Stroke Foundation fellowship, an Alberta Heritage Foundation for Medical Research fellowship, a Canadian Diabetes Association fellowship, a Physicians Services Inc Research Prize for outstanding research paper, a PMAC award, a Pfizer research prize, a Burroughs Wellcome Medical Research Council Award, a Young Clinician Scientist Award (1st prize) from the Canadian Association of Physicians of Indian Heritage, a Canadian Cardiovascular Society Young Investigator award (1st place), the Paul Cartier Cardiac Surgery Young Investigator Award and a Royal College of Physicians and Surgeons of Canada research award. At the international level, he has been honored with an American Heart Association Young Investigator award (1st Prize in Basic Cardiovascular Sciences), the Irvine Page Award in Atherosclerosis Thrombosis and Vascular Biology (finalist), a Society of Vascular Biology and Medicine Young Investigator award (finalist), an ISHR Young Investigator award (1st place), two American Association for Thoracic Surgery Young Investigator awards (finalist), a Paul Sampson Western Thoracic Society Young Investigator award (finalist), an Interamerican Society of Cardiology Young Investigator Award and the James T. Willerson Vul

As of 2002, Dr Verma’s research endeavors in the basic, translational and clinical sciences have been strongly supported by the Canadian Institutes of Health Research, the Heart and Stroke Foundation and the Canadian Diabetes Association in addition to grants from the Canadian pharmaceutical industry. This series of sound funding is unsurprising considering his exemplary publication record. Dr Verma has published extensively (over 160 peer-reviewed papers and nearly 300 abstracts) in a wide range of high-impact basic, translational and clinical science journals including the New England Journal of Medicine, Nature, Circulation, etc. He sits on several journal editorial boards and is a constant reviewer of more than twenty high-impact journals. Over the last five years, Dr Verma has presented nearly 200 guest lectures within and outside of Canada and he has been a Visiting Professor at thirteen international universities. As a trained pharmacist, pharmacologist, vascular biologist and cardiac surgeon, Dr Verma has a solid foundation in the basic, translational and clinical sciences. This has shaped him into a unique clinician-scientist. His productivity in the diverse research platforms speak towards his commitment in bridging the bench to the bedside with a breadth of research spanning cutting-edge basic science to clinical investigations. In short, Dr Verma and his laboratory are capable of offering dynamic, cross-disciplinary and innovative research training to national and international students and fellows.

www.ncbi.nlm.nih.gov/PubMed/